| Year |
Citation |
Score |
| 2020 |
Sheehan S, Baer G, Romine M, Hudson L, Lim R, Papadopoulos E, Campbell M, Daniel G, McCune S. Advancing Therapeutic Development for Pulmonary Morbidities Associated with Preterm Birth. Therapeutic Innovation & Regulatory Science. 54: 1312-1318. PMID 33258093 DOI: 10.1007/S43441-020-00153-Z |
0.322 |
|
| 2020 |
Orsini LS, Berger M, Crown W, Daniel G, Eichler HG, Goettsch W, Graff J, Guerino J, Jonsson P, Lederer NM, Monz B, Mullins CD, Schneeweiss S, Brunt DV, Wang SV, et al. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 23: 1128-1136. PMID 32940229 DOI: 10.1016/J.Jval.2020.04.002 |
0.367 |
|
| 2020 |
Orsini LS, Monz B, Mullins CD, Van Brunt D, Daniel G, Eichler HG, Graff J, Guerino J, Berger M, Lederer NM, Jonsson P, Schneeweiss S, Wang SV, Crown W, Goettsch W, et al. Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative. Pharmacoepidemiology and Drug Safety. PMID 32924243 DOI: 10.1002/Pds.5079 |
0.367 |
|
| 2020 |
Lopez MH, Daniel GW, Fiore NC, Higgins A, McClellan MB. Paying For Value From Costly Medical Technologies: A Framework For Applying Value-Based Payment Reforms. Health Affairs (Project Hope). 39: 1018-1025. PMID 32479217 DOI: 10.1377/Hlthaff.2019.00771 |
0.367 |
|
| 2019 |
Daniel GW, Romine MH, McClellan MB. Can Innovation in Regulatory Science Address Health Care Cost Burdens? Clinical Pharmacology and Therapeutics. PMID 30739326 DOI: 10.1002/Cpt.1334 |
0.323 |
|
| 2018 |
Richardson E, Burnell J, Adams HR, Bohannon RW, Bush EN, Campbell M, Chen WH, Coons SJ, Papadopoulos E, Reeve BR, Rooks D, Daniel G. Developing and Implementing Performance Outcome Assessments: Evidentiary, Methodologic, and Operational Considerations. Therapeutic Innovation & Regulatory Science. 2168479018772569. PMID 29739255 DOI: 10.1177/2168479018772569 |
0.346 |
|
| 2018 |
Richardson E, Daniel G, Joy DR, Kweder SL, Maloney DM, Raggio MJ, Jarow JP. Regional Approaches to Expedited Drug Development and Review: Can Regulatory Harmonization Improve Outcomes? Therapeutic Innovation & Regulatory Science. 2168479018764664. PMID 29714587 DOI: 10.1177/2168479018764664 |
0.337 |
|
| 2017 |
Sorenson C, Lavezzari G, Daniel G, Burkholder R, Boutin M, Pezalla E, Sanders G, McClellan M. Advancing Value Assessment in the United States: A Multistakeholder Perspective. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 20: 299-307. PMID 28237214 DOI: 10.1016/J.Jval.2016.11.030 |
0.337 |
|
| 2016 |
Zineh I, Abernethy D, Hop CE, Bello A, McClellan MB, Daniel GW, Romine MH. Improving the Tools of Clinical Pharmacology: Goals for 2017 and Beyond. Clinical Pharmacology and Therapeutics. PMID 27727433 DOI: 10.1002/Cpt.530 |
0.365 |
|
| 2016 |
Audibert C, Romine M, Caze A, Daniel G, Leff J, McClellan M. Building a Drug Development Database: Challenges in Reliable Data Availability. Drug Development and Industrial Pharmacy. 1-19. PMID 27494335 DOI: 10.1080/03639045.2016.1220565 |
0.322 |
|
| 2016 |
Bao YC, Blanchette CM, Burke L, Cashman L, Cobbs EJ, Daniel G, Danielson D, Francer JK, Graff J, Hay JW, Hoverman R, Jackson J, Malone DC, Marttila JK, Mattson C, et al. AMCP partnership forum: FDAMA section 114-improving the exchange of health care economic data Journal of Managed Care and Specialty Pharmacy. 22: 826-831. DOI: 10.18553/Jmcp.2016.22.7.826 |
0.487 |
|
| 2015 |
McClellan MB, Daniel GW, Dickson D, Perlmutter J, Berger DP, Miller V, Nussbaum S, Malin J, Romine MH, Schilsky RL. Improving evidence developed from population-level experience with targeted agents. Clinical Pharmacology and Therapeutics. 97: 478-87. PMID 25676878 DOI: 10.1002/Cpt.90 |
0.327 |
|
| 2015 |
Daniel GW, Cazé A, Romine MH, Audibert C, Leff JS, McClellan MB. Improving pharmaceutical innovation by building a more comprehensive database on drug development and use. Health Affairs (Project Hope). 34: 319-27. PMID 25646113 DOI: 10.1377/Hlthaff.2014.1019 |
0.354 |
|
| 2015 |
Outterson K, Powers JH, Daniel GW, McClellan MB. Repairing the broken market for antibiotic innovation. Health Affairs (Project Hope). 34: 277-85. PMID 25646108 DOI: 10.1377/Hlthaff.2014.1003 |
0.339 |
|
| 2013 |
Cutrona SL, Toh S, Iyer A, Foy S, Daniel GW, Nair VP, Ng D, Butler MG, Boudreau D, Forrow S, Goldberg R, Gore J, McManus D, Racoosin JA, Gurwitz JH. Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program. Pharmacoepidemiology and Drug Safety. 22: 40-54. PMID 22745038 DOI: 10.1002/Pds.3310 |
0.31 |
|
| 2012 |
Gagne JJ, Glynn RJ, Rassen JA, Walker AM, Daniel GW, Sridhar G, Schneeweiss S. Active safety monitoring of newly marketed medications in a distributed data network: Application of a semi-automated monitoring system Clinical Pharmacology and Therapeutics. 92: 80-86. PMID 22588606 DOI: 10.1038/Clpt.2011.369 |
0.332 |
|
| 2012 |
Eisenberg DF, Daniel GW, Jones JK, Goehring EL, Wahl PM, Winters P, Levin J, Bohn RL. Validation of a claims-based diagnostic code for Stevens-Johnson syndrome in a commercially insured population. Pharmacoepidemiology and Drug Safety. 21: 760-764. PMID 22539145 DOI: 10.1002/Pds.3276 |
0.326 |
|
| 2012 |
Curtis LH, Weiner MG, Boudreau DM, Cooper WO, Daniel GW, Nair VP, Raebel MA, Beaulieu NU, Rosofsky R, Woodworth TS, Brown JS. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiology and Drug Safety. 21: 23-31. PMID 22262590 DOI: 10.1002/Pds.2336 |
0.312 |
|
| 2010 |
Croghan TW, Esposito D, Daniel G, Wahl P, Stoto MA. Using medical records to supplement a claims-based comparative effectiveness analysis of antidepressants. Pharmacoepidemiology and Drug Safety. 19: 814-8. PMID 20681000 DOI: 10.1002/Pds.1988 |
0.338 |
|
| 2010 |
Daniel GW, Ewen E, Willey VJ, Reese Iv CL, Shirazi F, Malone DC. Efficiency and economic benefits of a payer-based electronic health record in an emergency department. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 17: 824-33. PMID 20670319 DOI: 10.1111/J.1553-2712.2010.00816.X |
0.5 |
|
| 2010 |
Brophy DF, Daniel G, Gitlin M, Mayne TJ. Characterizing Hospitalizations of End-Stage Renal Disease Patients on Dialysis and Inpatient Utilization of Erythropoiesis-Stimulating Agent Therapy Annals of Pharmacotherapy. 44: 43-49. PMID 20028955 DOI: 10.1345/Aph.1M429 |
0.307 |
|
| 2009 |
Daniel G, Hurley D, Whyte JL, Willey V, Wilson M, Kallich J. Use and cost of erythropoiesis-stimulating agents in patients with cancer. Current Medical Research and Opinion. 25: 1775-84. PMID 19505205 DOI: 10.1185/03007990903001150 |
0.319 |
|
| 2009 |
Daniel G, Ewen E, Willey V, Shirazi M, Malone D. HM1 EFFICIENCY AND ECONOMIC BENEFITS ASSOCIATED WITH THE USE OF A PAYER-BASED ELECTRONIC HEALTH RECORD IN AN EMERGENCY DEPARTMENT AMONG A HEALTH INSURED POPULATION Value in Health. 12: A14. DOI: 10.1016/S1098-3015(10)73130-2 |
0.506 |
|
| 2008 |
Brophy D, Harley C, Chastek B, Daniel G, McNeeley B, Gitlin M, Mayne TJ. 37: Inpatient Use of Erythropoiesis Stimulating Agents (ESA) Among Commercially-Insured Dialysis Patients American Journal of Kidney Diseases. 51. DOI: 10.1053/J.Ajkd.2008.02.042 |
0.317 |
|
| 2008 |
Esposito D, Wahl P, Daniel G, Stoto M, Erder M, Croghan T. Pmh24 Initiating Treatment On Generic Antidepressants May Not Save Health Care Costs Value in Health. 11. DOI: 10.1016/S1098-3015(10)70373-9 |
0.318 |
|
| 2007 |
Daniel GW, Malone DC. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs. Journal of Managed Care Pharmacy : Jmcp. 13: 142-54. PMID 17330975 DOI: 10.18553/Jmcp.2007.13.2.142 |
0.491 |
|
| 2007 |
Daniel GW, Hurley DL, Whyte JL, Grochulski WD, Willey VJ, Kallich JD. Erythropoietin stimulating agent dose and use patterns in cancer patients Journal of Clinical Oncology. 25: 19547-19547. DOI: 10.1200/Jco.2007.25.18_Suppl.19547 |
0.304 |
|
| Show low-probability matches. |